Guangdong Yikangnas Biomedical Technology Co., Ltd.
广东伊康纳斯生物医药科技股份有限公司
Guangzhou, Guangdong
- Founded
- 2001
- Registered capital
- ¥60.0m
- Company size
- 150~500
- Location
- Guangzhou, Guangdong
Products
ELISA Kits, Protein Assay Kits, Cell Culture Media, Antibodies, Proteins, Peptides, Nucleic Acids, Recombinant Proteins, Research Chemicals, Biotechnology Services
Compared with other factories in Guangzhou
We track 426 manufacturers in Guangzhou.
Median registered capital among them is ¥5.0m; this company is above that figure at ¥60.0m.
The average local manufacturer was registered in 2008, making this one of the older factories in the city.
About
Guangdong Yikangnas Biomedical Technology Co., Ltd. is a factory located in Guangzhou, Guangdong. Its product range includes ELISA Kits, Protein Assay Kits, Cell Culture Media, Antibodies, Proteins, Peptides. It was founded in 2001.
Operating history
Operating since 2001 · registered capital ¥60.0m
A long operating history is one signal among several; it does not by itself indicate export experience or quality control.
Export readiness
Holds High-Tech Enterprise status
Shipping
Nearest export port: Guangzhou (Nansha)
Typical sea freight transit — Europe 28–35 days, US West Coast 15–20 days.
Website
Looking to source from this factory?
We do not publish the personal contact details of individuals. Our sourcing service contacts the factory in Chinese, asks for MOQ, pricing and lead time, and introduces you directly — from Shanghai, with no markup on the factory price.
A registry check reads the Chinese government record: licence status, paid-in against registered capital, legal representative, court judgments and any listing for unpaid enforcement.
Other health food & traditional medicine manufacturers
Trade shows for food & beverage
Where this factory's industry exhibits — a chance to meet it, and its competitors, in person.
- WPE & WHPE – WORLD OF PLANT EXTRACTS & INNOVATIVE NATURAL INGREDIENTS EXPOXi'an24 Aug 2026
- ALLFOOD EXPOShanghai26 Aug 2026
- CFIEShanghai26 Aug 2026